Blog
Clinical insights, research updates, and expert commentary from Dr Adrian Hunt.
Sunscreen Under Scrutiny — Don't Forget Your Eyes
Sunscreen efficacy has been questioned by recent TGA reviews and independent SPF testing. The conversation has mostly skipped the eyes — where a daily protection routine matters as much as any cream.
Cosmetic and Halloween Contact Lenses: Why Unregulated Lenses Put Your Eyes at Risk
The TGA is reviewing the regulation of cosmetic contact lenses in Australia. Dr Hunt explains the risks of unregulated lenses and what to look for if something goes wrong.
Ozempic and Eye Stroke: What Patients on GLP-1 Drugs Need to Know
An emerging safety signal links semaglutide (Ozempic, Wegovy) to a rare form of eye stroke called NAION. Dr Hunt explains what the evidence shows, what the TGA has done, and when to seek urgent eye care.
PhD Conferral — University of Sydney
Dr Adrian Hunt was conferred his PhD at the University of Sydney on 3 December 2025.
miVision — Retinal Vein Occlusion: Current and Future Management
Dr Hunt authored an article in miVision on the current state and future directions of retinal vein occlusion management.
How Treatment Intensity Varies in Retinal Vein Occlusion — and Why It Matters
Dr Hunt's research revealing how widely ophthalmologists differ in how frequently they treat retinal vein occlusion — from RANZCO Best Paper to AAO international recognition.
Switching to Faricimab for Wet Macular Degeneration — What the Evidence Shows
Dr Hunt's research on what happens when patients with wet AMD switch from established injections to faricimab — presented at ASRS and selected as AAO Editor's Choice.
miVision — FRB! Research: So Much More Than Number Crunching
Dr Hunt authored an article in miVision explaining how Fight Retinal Blindness! registry research translates into better patient care.
EURETINA 2023 — Presentation at Euretina in Amsterdam
Dr Hunt presented research on attempted cessation of VEGF inhibitors in retinal vein occlusion at EURETINA 2023 in Amsterdam.
HealthED Clinical Takeaway Podcast — Macular Degeneration Prevention
Dr Hunt was a guest on the HealthED Clinical Takeaway podcast, discussing macular degeneration prevention for GPs and primary care clinicians.
Three-Year Injection Outcomes for Central Retinal Vein Occlusion
Dr Hunt's research tracking CRVO patients from first injection through three years of treatment — published in Ophthalmology Retina and featured across Australasian eye-care media.
Hemiretinal Vein Occlusion — A Unique Entity That Responds Well to Treatment
Dr Hunt's research establishing hemiretinal vein occlusion as a distinct condition with its own treatment profile — not just a variant of branch or central RVO.
Comparing Injection Treatments for Retinal Vein Occlusion — Ranibizumab vs Aflibercept
Dr Hunt's research comparing the two main anti-VEGF agents for RVO — a EURETINA Prize Paper that became one of Acta Ophthalmologica's most downloaded articles.